Back to search

University of British Columbia

Developing next-generation regulatory T cell therapeutics

Abstract

dc:description

CD4⁺FOXP3⁺ regulatory T cells (Tregs) control inflammation and enforce self-tolerance to maintain immune homeostasis. Adoptive Treg cell therapy holds promise for a variety of immune-mediated conditions, including transplant rejection and autoimmune disease. The last decade has seen an increased appreciation for Treg heterogeneity and hence an untapped potential for therapeutic Tregs with tailored functional profiles. We aimed to enable the development of next-generation Treg cell therapies by investigating novel Treg functions, optimizing gene editing tools, and interrogating the parameters essential for optimal Treg stability and efficacy. First, we examined the potential of human Tregs to directly mediate tissue repair. In contrast to mouse models, human Tregs did not express the IL-33 receptor ST2, but Tregs engineered to overexpress ST2 exhibited several tissue-reparative features, including amphiregulin expression and a heightened ability to induce M2-like macrophages. Second, we optimized a CRISPR-based approach to knock-out/knock-in genes in human Tregs. Using this method, we found that the master transcription factor FOXP3 had subset-specific roles in regulating mature Treg function and a limited role in maintaining lineage identity. Finally, we applied genome editing in human Tregs to interrogate the role of the transcription factor Helios, implicated in mouse Treg stability. Human Tregs that spontaneously downregulated Helios expression during in vitro expansion exhibited phenotypic and functional instability, but CRISPR-based Helios-knockout Tregs did not exhibit discernable functional defects. Overall, this work highlights important species-specific considerations in the translation of biology to therapy and offers a method to explore future mechanistic questions in human Tregs.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lam, Avery Justin
Contributors dc:contributor
  • Levings, Megan K.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/79230

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Lam, Avery Justin. Developing next-generation regulatory T cell therapeutics. doctoral thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/79230